Journal article
The relationship of provider organizational status and erythropoietin dosing in end stage renal disease patients.
- Abstract:
-
Controversy exists as to whether provider organizational characteristics such as profit status and setting are associated with the content of medical care or efficiency with which care is rendered. Following FDA approval of human recombinant erythropoietin (EPO) for use in clinical practice, Medicare approved coverage for beneficiaries in its end stage renal disease program and established a fixed payment per dose. Because cost of EPO administration varied positively with dose, providers coul...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Medical care
- Volume:
- 32
- Issue:
- 2
- Pages:
- 130-140
- Publication date:
- 1994-02-01
- DOI:
- EISSN:
-
1537-1948
- ISSN:
-
0025-7079
- Source identifiers:
-
359137
Item Description
- Language:
- English
- Keywords:
- Pubs id:
-
pubs:359137
- UUID:
-
uuid:6e0911cb-a479-4800-bad5-599c1a8e0755
- Local pid:
- pubs:359137
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 1994
If you are the owner of this record, you can report an update to it here: Report update to this record